Cookies on Pinsent Masons website

This website uses cookies to allow us to see how the site is used. The cookies cannot identify you. If you continue to use this site we will assume that you are happy with this

If you want to use the sites without cookies or would like to know more, you can do that here.

Five years on the Bribery Act has led to a 'step-change' in anti-bribery compliance standards, says expert

FOCUS: The Bribery Act, which was enacted exactly five years ago, may not have resulted in any prosecutions but corporate complacency about the UK's first dedicated anti-bribery law is misguided. The Bribery Act has led to a step-change in anti-bribery compliance... 21 Apr 2015

Concerns over SFO funding as few whistleblowing reports lead to investigations

The UK's Serious Fraud Office (SFO) only opened 12 new investigations into suspected fraud or corruption over the year ending 31 March 2014, despite receiving over 2,500 reports through its confidential whistleblowing service over a similar period. 13 Apr 2015

Out-Law Guides

  • How DPAs could affect D&O insurers

    Deferred prosecution agreements (DPAs) are a way for authorities and companies to settle certain kinds of disputes involving allegations of corporate criminal misconduct. Their use could have implications for directors and officers liability (D&O) insurance....

UK multi-agency anti-money laundering drive will give law enforcement better oversight of suspicious accounts, says expert

A recently-announced joint initiative between the government, banks and law enforcement agencies could give those investigating suspected money laundering offences better oversight of suspicious accounts, an expert has said. 09 Apr 2015

Germany to stop pharmaceuticals offering doctors 'benefits' for prescribing their drugs

Pharmaceuticals companies will no longer to able to offer "benefits" to doctors in Germany to encourage them to prescribe their drugs, once an update to the country's criminal code comes into force.  02 Apr 2015

More stories